Novel compound shows in vivo anthelmintic activity in gerbils and sheep infected by Haemonchus contortus

© 2022. The Author(s)..

The control of gastrointestinal nematodes in livestock is becoming increasingly difficult due to the limited number of available drugs and the rapid development of anthelmintic resistance. Therefore, it is imperative to develop new anthelmintics that are effective against nematodes. Under this context, we tested the potential toxicity of three compounds in mice and their potential anthelmintic efficacy in Mongolian gerbils infected with Haemonchus contortus. The compounds were selected from previous in vitro experiments: two diamine (AAD-1 and AAD-2) and one benzimidazole (2aBZ) derivatives. 2aBZ was also selected to test its efficacy in sheep. In Mongolian gerbils, the benzimidazole reduced the percentage of pre-adults present in the stomach of gerbils by 95% at a dose of 200 mg/kg. In sheep, there was a 99% reduction in the number of eggs shed in faeces after 7 days at a dose of 120 mg/kg and a 95% reduction in the number of worm adults present in the abomasum. In conclusion, 2aBZ could be considered a promising candidate for the treatment of helminth infections in small ruminants.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Scientific reports - 12(2022), 1 vom: 29. Juli, Seite 13004

Sprache:

Englisch

Beteiligte Personen:

Valderas-García, Elora [VerfasserIn]
Escala, Nerea [VerfasserIn]
Álvarez-Bardón, María [VerfasserIn]
Castilla-Gómez de Agüero, Verónica [VerfasserIn]
Cambra-Pellejà, Maria [VerfasserIn]
González Del Palacio, Laura [VerfasserIn]
Vallejo García, Raquel [VerfasserIn]
de la Vega, Jennifer [VerfasserIn]
San Feliciano, Arturo [VerfasserIn]
Del Olmo, Esther [VerfasserIn]
Martínez-Valladares, María [VerfasserIn]
Balaña-Fouce, Rafael [VerfasserIn]

Links:

Volltext

Themen:

Anthelmintics
Benzimidazoles
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 02.08.2022

Date Revised 11.10.2022

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-022-17112-3

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM344260712